ClariVest Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-33,894
| Closed | -$1.15M | – | 769 |
|
|
2023
Q2 | $1.15M | Sell |
33,894
-26,114
| -44% | -$888K | 0.06% | 221 |
|
|
2023
Q1 | $2.16M | Sell |
60,008
-12,328
| -17% | -$444K | 0.1% | 163 |
|
|
2022
Q4 | $3.23M | Sell |
72,336
-583
| -0.8% | -$26K | 0.16% | 115 |
|
|
2022
Q3 | $2.05M | Buy |
72,919
+56,519
| +345% | +$1.59M | 0.1% | 162 |
|
|
2022
Q2 | $442K | Hold |
16,400
| – | – | 0.02% | 389 |
|
|
2022
Q1 | $559K | Sell |
16,400
-2,300
| -12% | -$78.4K | 0.02% | 368 |
|
|
2021
Q4 | $722K | Sell |
18,700
-14,600
| -44% | -$564K | 0.02% | 379 |
|
|
2021
Q3 | $1.8M | Sell |
33,300
-200
| -0.6% | -$10.8K | 0.06% | 246 |
|
|
2021
Q2 | $1.12M | Buy |
+33,500
| New | +$1.12M | 0.04% | 279 |
|